BioLife Solutions - BLFS Net Assets per Single Share

Graphic logo of BioLife Solutions, Inc. (BLFS)

BioLife Solutions, Inc. (BLFS) develops intelligent containers and biopreservation environments, ensuring the integrity of valuable samples during transport. Serving as the primary valuation tool, this price chart demonstrates the asset's dynamics, where the key indicator is 8.53. The business provides cryogenic support for oncology therapies, while high margins in the genetic engineering sector support a steady cash flow and liquidity.

BioLife Corp (BLFS) Equity per Share: for the period 07/04/2022 - 10/18/2026
Manufactured products of biolifesolutions.com

Developing automated cryopreservation systems requires significant capital expenditures in the technological infrastructure of BioLife Solutions, Inc. (BLFS). Book value per share is calculated as the difference between total assets and liabilities, divided by the number of outstanding shares. This metric determines the intrinsic value of the business, stripped of market volatility. An increase in this indicator signals the effective accumulation of equity. The historical book value per share data visualizes this fundamental trend.

Competitor analysis for BioLife Solutions, Inc.

Book Value per Share Tempus AI, Inc.|QGEN: Share Book Value|Ionis Pharmaceuticals - Net Assets per Single Share|repligen.com (RGEN) - Net Assets per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|Book Value per Share sarepta.com SRPT|TWST - Book Value per Share|TXG - Net Assets per Single Share|Intellia - Book Value per Share|STOK (Stoke Corp) - Net Assets per Share|Net Assets per Single Share WVE (Wave Life Sciences)|Net Asset Value per Share MAZE|Net Assets per Single Share Sionna Therapeutics (SION)|Net Assets per Single Share Prime Medicine Inc (PRME)|Book Value per Share TSHA|Net Assets per Share uniQure Pharma QURE|Book Value per Share MeiraGTx Holdings plc|RGNX - Share Book Value|Book Value per Share SLDB|Net Asset Value per Share Ocugen Inc|PACB - Accounting Value per Share|Accounting Value of a Share BNTC|DSGN (Design Therapeutics) - Net Assets per Single Share|Net Assets per Share RCKT (rocketpharma.com)|FDMT: Net Assets per Single Share|Lexeo Therapeutics Inc. - Net Asset Value per Share|KRRO - Net Assets per Single Share|Editas Corp (EDIT) - Net Assets per Single Share|SLN: Accounting Value per Share|Book Value per Share ProQR Therapeutics|Codexis Inc (CDXS) - Accounting Value per Share|Book Price of a Share Sangamo Therapeutics Inc.|NAUT (Nautilus Biotechnology) - Book Value per Share|Net Assets per Share MGX (Metagenomi Therapeutics)|DTIL: Net Assets per Single Share|Generation Bio Co - Net Asset Value per Share|Boundless Bio (BOLD) - Net Assets per Single Share|XCUR: Equity per Share|imunon.com - Net Assets per Single Share|Net Assets per Share Phio Pharmaceuticals Corp.|MBIO - Accounting Value per Share|Accounting Value of a Share TransCode|BNGO (Bionano Genomics, Inc.) - Book Value per Share|Net Assets per Share APDN (Applied DNA Sciences Inc)|BLUE - Net Assets per Single Share|Equity per Share ImmunoPrecise Antibodies Ltd IPA|OMGA: Book Value per Share|singulargenomics.com (OMIC) - Accounting Value per Share|Regulus Therapeutics Inc. - Accounting Value per Share|Syros Pharmaceuticals Inc. (SYRS) - Net Assets per Share|Book Value per Share Codex DNA|Net Assets per Single Share TCON|Net Assets per Single Share Unity Biotechnology (UBX)